AKT1 and nasopharyngeal carcinoma: In NPC, the resistance to radiotherapy is primarily mediated by EBV-encoded products (such as LMP1) and non-coding RNAs (miRNA/lncRNA/circRNA), which inhibit DNA damage repair, activate anti-apoptotic pathways (such as PI3K/AKT, NF-κB), and promote EMT.